BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
0.789
+0.187 (31.00%)
At close: Nov 21, 2024, 4:00 PM
0.765
-0.024 (-3.04%)
After-hours: Nov 21, 2024, 6:54 PM EST
BriaCell Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is August - July.
Millions USD. Fiscal year is Aug - Jul.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Jul '24 Jul 31, 2024 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 | Jul '20 Jul 31, 2020 |
| Net Income | -4.79 | -4.79 | -20.3 | -26.84 | -13.82 | -4.02 | |
| Depreciation & Amortization | 0.08 | 0.08 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Loss (Gain) on Equity Investments | 0.11 | 0.11 | - | - | - | - | |
| Stock-Based Compensation | 1.8 | 1.8 | 2.19 | 3.07 | 1.97 | 0 | |
| Other Operating Activities | -28.38 | -28.38 | -2.12 | 11.66 | 6.36 | 0.08 | |
| Change in Accounts Receivable | -0.73 | -0.73 | 0.01 | -0.01 | 0.01 | -0.02 | |
| Change in Accounts Payable | 6.05 | 6.05 | 0.66 | 0.25 | -1.41 | 2.91 | |
| Change in Other Net Operating Assets | 1.74 | 1.74 | -4.2 | -0.63 | -0.89 | -0.22 | |
| Operating Cash Flow | -24.13 | -24.13 | -23.74 | -12.48 | -7.75 | -1.27 | |
| Capital Expenditures | -0.46 | -0.46 | - | - | - | - | |
| Investment in Securities | -0.23 | -0.23 | - | - | - | - | |
| Investing Cash Flow | -0.68 | -0.68 | - | - | - | - | |
| Short-Term Debt Issued | - | - | - | - | 0.22 | 0.41 | |
| Total Debt Issued | - | - | - | - | 0.22 | 0.41 | |
| Short-Term Debt Repaid | - | - | - | - | -0.55 | -0.39 | |
| Total Debt Repaid | - | - | - | - | -0.55 | -0.39 | |
| Net Debt Issued (Repaid) | - | - | - | - | -0.33 | 0.02 | |
| Issuance of Common Stock | 4.42 | 4.42 | 4 | 6.51 | 65.33 | 1.15 | |
| Repurchase of Common Stock | - | - | -0.05 | -10.17 | - | - | |
| Other Financing Activities | - | - | - | -0.08 | - | - | |
| Financing Cash Flow | 4.42 | 4.42 | 3.95 | -3.74 | 65 | 1.17 | |
| Foreign Exchange Rate Adjustments | - | - | - | - | - | -0.04 | |
| Net Cash Flow | -20.39 | -20.39 | -19.79 | -16.23 | 57.25 | -0.14 | |
| Free Cash Flow | -24.58 | -24.58 | -23.74 | -12.48 | -7.75 | -1.27 | |
| Free Cash Flow Per Share | -1.49 | -1.49 | -1.52 | -0.81 | -1.71 | -1.77 | |
| Levered Free Cash Flow | -10.83 | -10.83 | -15.87 | -6.86 | -5.83 | 0.21 | |
| Unlevered Free Cash Flow | -10.83 | -10.83 | -15.87 | -6.86 | -5.78 | 0.23 | |
| Change in Net Working Capital | -8.57 | -8.57 | 3.53 | 0.39 | 3.45 | -2.67 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.